{"nct_id":"NCT00171899","title":"Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)","status":"COMPLETED","status_verified_date":"2017-02","start_date":"2005-04","start_date_type":null,"primary_completion_date":"2007-06","primary_completion_date_type":"ACTUAL","completion_date":"2007-06","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}